Showing results (21-30 of 43) with videos related to
Sort By:
Pageof 5
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 29, 2021
Affibody-Mediated PNA-Based Pretargeted Cotreatment Improves Survival of Trastuzumab-Treated Mice Bearing HER2-Expressing XenograftsMaryam Oroujeni, Hanna Tano, Anzhelika Vorobyeva, et al.International Journal of Molecular Sciences|April 3, 2021
Preclinical Evaluation of 99mTc-ZHER2:41071, a Second-Generation Affibody-Based HER2-Visualizing Imaging Probe with a Low Renal UptakeMaryam Oroujeni, Sara S Rinne, Anzhelika Vorobyeva, et al.EJNMMI Radiopharmacy and Chemistry|May 30, 2025
Selection of the optimal chelator for labeling of DARPin Ec1 with gallium-68 for PET imaging of EpCAM expressionAnzhelika Vorobyeva, Moeen-Ud Din, Alexey Schulga, et al.International Journal of Molecular Sciences|December 11, 2022
Direct In Vivo Comparison of 99mTc-Labeled Scaffold Proteins, DARPin G3 and ADAPT6, for Visualization of HER2 Expression and Monitoring of Early Response for Trastuzumab TherapyVladimir Tolmachev, Vitalina Bodenko, Maryam Oroujeni, et al.Pharmaceutics|March 26, 2022
Effect of Inter-Domain Linker Composition on Biodistribution of ABD-Fused Affibody-Drug Conjugates Targeting HER2Tianqi Xu, Jie Zhang, Maryam Oroujeni, et al.Pharmaceutics|March 6, 2021
The Use of a Non-Conventional Long-Lived Gallium Radioisotope 66Ga Improves Imaging Contrast of EGFR Expression in Malignant Tumours Using DFO-ZEGFR:2377 Affibody MoleculeMaryam Oroujeni, Tianqi Xu, Katherine Gagnon, et al.ACS Pharmacology & Translational Science|May 16, 2024
Shorter Peptide Nucleic Acid Probes Improve Affibody-Mediated Peptide Nucleic Acid-Based PretargetingKristina Westerlund, Maryam Oroujeni, Maxime Gestin, et al.European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|November 9, 2018
Comparative evaluation of dimeric and monomeric forms of ADAPT scaffold protein for targeting of HER2-expressing tumoursJavad Garousi, Sarah Lindbo, Jesper Borin, et al.Pharmaceutics|November 27, 2021
The Influence of Domain Permutations of an Albumin-Binding Domain-Fused HER2-Targeting Affibody-Based Drug Conjugate on Tumor Cell Proliferation and Therapy EfficacyWen Yin, Tianqi Xu, Mohamed Altai, et al.Pharmaceutics|September 23, 2022
Evaluation of an Affibody-Based Binder for Imaging of Immune Check-Point Molecule B7-H3Maryam Oroujeni, Ekaterina A Bezverkhniaia, Tianqi Xu, et al.Pageof 5